Cargando…
Harnessing neutrophil plasticity for HCC immunotherapy
Neutrophils, until recently, have typically been considered a homogeneous population of terminally differentiated cells with highly conserved functions in homeostasis and disease. In hepatocellular carcinoma (HCC), tumour-associated neutrophils (TANs) are predominantly thought to play a pro-tumour r...
Autores principales: | Ramon-Gil, Erik, Geh, Daniel, Leslie, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539947/ https://www.ncbi.nlm.nih.gov/pubmed/37534829 http://dx.doi.org/10.1042/EBC20220245 |
Ejemplares similares
-
CXCR2 inhibition enables NASH-HCC immunotherapy
por: Leslie, Jack, et al.
Publicado: (2022) -
Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
por: Gu, Yuanzhuo, et al.
Publicado: (2023) -
NAFLD-Associated HCC: Progress and Opportunities
por: Geh, Daniel, et al.
Publicado: (2021) -
The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021) -
Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients
por: Gkountakos, Anastasios, et al.
Publicado: (2021)